GlassScriptPhysician profile
Maria J Ramirez
NPI 1194109819
$7,170.56
in general payments reported to CMS, 2019-2025
22 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,202 · 2022: $1,092 · 2023: $1,456 · 2024: $2,273 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,876.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,749.25 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Braeburn INC. | $1,293.42 | 2023-2025 | Brixadi |
| Indivior INC. | $1,150.11 | 2021-2025 | Sublocade |
| Astrazeneca Pharmaceuticals LP | $803.85 | 2021-2025 | Breztri, Enhertu, Airsupra |
| Abbvie INC. | $501.45 | 2021-2024 | |
| Gilead Sciences, INC. | $315.83 | 2021-2025 | Epclusa |
| Amarin Pharma, INC. | $257.74 | 2021-2022 | |
| Alkermes, INC. | $226.49 | 2021-2025 | Vivitrol, Vivitrol |
| Inari Medical, INC. | $165.07 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Scilex Pharmaceuticals INC. | $126.07 | 2021-2025 | |
| Novo Nordisk INC | $122.83 | 2021 | |
| Mannkind Corporation | $112.91 | 2021 | |
| Stryker Corporation | $94.86 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Althera Pharmaceuticals LLC | $61.68 | 2021-2022 | |
| Horizon Therapeutics Plc | $49.61 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $34.69 | 2025 | Mounjaro, Zepbound |
| Hologic Sales and Service, LLC | $27.99 | 2024 | Aptima |
| Emd Serono, INC. | $18.41 | 2021 | |
| Sk Life Science, INC. | $15.61 | 2022 | |
| Janssen Biotech, INC. | $15.15 | 2025 | Tecvayli |
| Sun Pharmaceutical Industries INC. | $14.08 | 2021 | |
| Phadia US INC. | $13.46 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.